Global Chronic Kidney Disease (CKD) Drugs Market 2015-2019

Global Chronic Kidney Disease (CKD) Drugs Market 2015-2019

  • March 2015 •
  • 103 pages •
  • Report ID: 2779345 •
  • Format: PDF
About
According to WHO, CKD is not only common, treatable, and harmful but also a major contributing factor to the incidence and outcomes of at least three of the diseases that are targeted by WHO (hypertension, diabetes, and CVD). CKD is mainly defined as a reduced GFR, increased urinary albumin excretion, or both, and is growing public health issue. CKD is classified into five stages (stages 1-5) according to renal function and the level of urinary protein excretion as measured by eGFR which is derived from race, gender, age, and serum creatinine concentration.

TechNavio's analysts forecast the Global CKD Drugs market to grow at a CAGR of 1.21 percent over the period 2014-2019.


Covered in this Report
The Global CKD Drugs Market can be divided into two segments: Route of Administration which includes oral, SC, and IV and Mechanism of Action which includes ARBs, ACEIs, ESAs, PH Binders, and Vasodilators. This report covers the present scenario and the growth prospects of the Global CKD Drugs market for the period 2014–2019. To calculate the market size, the report considers the revenue generated from the sales of various drugs used in the treatment of CKD that are available in the market.

TechNavio's report, the Global CKD Drugs Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, the EMEA and APAC regions; it also covers the Global CKD Drugs market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.


Key Regions
• Americas
• EMEA
• APAC


Key Vendors
• Actavis PLC
• Amgen Inc.
• Johnson & Johnson
• F. Hoffmann-La Roche Ltd
• Sanofi

Other Prominent Vendors
• Abbott Laboratories
• Akebia Therapeutics
• AMAG Pharmaceuticals
• Cara Therapeutics
• FibroGen
• Keryx Biopharmaceuticals
• Reata Pharmaceuticals
• OPKO Health
• Pharmacosmos
• Raptor Pharmaceuticals
• Regulus Therapeutics
• Rockwell Medical
• Shield Therapeutics
• Takeda Pharmaceuticals
• Vifor Pharma Ltd
• Xenetic Biosciences
• ZS Pharma


Market Driver
• Increase in Associated Disorders with CKD
• For a full, detailed list, view our report


Market Challenge
• Genericization of Major Brands
• For a full, detailed list, view our report


Market Trend
• Approval of New Pipeline Drugs
• For a full, detailed list, view our report


Key Questions Answered in this Report
• What will the market size be in 2019 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
Loading...

We are very sorry, but an error occurred.
Please contact support@reportbuyer.com if the problem remains.